Detection of genomic variants in BRCA1 and BRCA2 across gastric cancer patients using next generation sequencing

被引:0
|
作者
Li, Fangfang
Abdel-Maksoud, Mostafa A. [1 ,2 ]
Ullah, Tahir [3 ]
Ul Haq, Moeen [4 ]
Khan, Abdurrehman [5 ]
Olatunji, Aliu Olalekan [6 ]
Abbasi, Bakar Bin Khatab [7 ]
Saleh, Ibrahim A. [8 ]
Rather, Mehak Nabi [9 ]
Al-Hawadi, Jehad S. [8 ]
Zomot, Naser [8 ]
Almutairi, Saeedah Musaed
Naz, Rida [10 ]
机构
[1] Jiaozhou Cent Hosp Qingdao, Dept Gastroenterol, Qingdao 266300, Shandong, Peoples R China
[2] King Saud Univ, Coll Sci, Bot & Microbiol Dept, POB 2455, Riyadh 11451, Saudi Arabia
[3] Bannu Med Coll, Bannu 28100, Pakistan
[4] Gomal Med Coll, Dera Ismail Khan 29050, Pakistan
[5] Gomal Med Coll, Med Dept, Dera Ismail Khan, Pakistan
[6] Inst Univ Toledo, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA
[7] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA
[8] Zarqa Univ, Fac Sci, Zarqa 13110, Jordan
[9] North End Hosp, Taper Wari Pora, J&K, India
[10] Reg Blood Ctr, Dera Ismail Khan 29050, Pakistan
来源
关键词
Gastric cancer; NGS; BRCA genes; NEGATIVE BREAST-CANCER; GENE-EXPRESSION; DNA-REPAIR; MUTATIONS; THERAPY; PROGNOSIS; CARCINOMA; PATTERNS; SURVIVAL; PLATFORM;
D O I
10.62347/MRIE2131
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To explore the landscape of BRCA1/2 mutations in gastric cancer patients. Methods: Next- generation sequencing (NGS), Sanger sequencing, reverse transcription quantitative polymerase chain reaction (RTqPCR), Immunohistochemistry, The Cancer Genome Atlas (TCGA), gnomAD, and DAVID. Results: With 95% of bases boasting a phred score surpassing 30 and a minimum coverage depth of 500X, our NGS approach ensures high- quality data acquisition. Analyzing BRCA1 and BRCA2 sequences revealed 11 and 4 mutations, respectively, with one pathogenic mutation identified in each gene. This emphasizes the prominence of BRCA1 mutations in gastric cancer. Sanger sequencing validation confirmed the presence of pathogenic mutations in select cases, consolidating our findings. Frequency analysis utilizing the gnomAD database elucidated the rarity of these mutations in the Asian population, underscoring their uniqueness. Exploring TCGA data further corroborated this rarity, emphasizing the distinctive nature of these mutations in gastric cancer. RT-qPCR analysis unveiled a significant reduction in BRCA1/2 expression in samples harboring pathogenic mutations, hinting at their potential role in down-regulating gene expression. Immunohistochemistry confirmed diminished protein expression in samples with pathogenic mutations, solidifying our observations. Kaplan-Meier survival analysis demonstrated significantly poorer survival outcomes for patients with pathogenic BRCA1/2 mutations compared to those without, emphasizing their potential role in prognosis. Additionally, KEGG pathway analysis highlighted the involvement of BRCA1/2 in critical cancer- associated pathways, emphasizingtheir role in tumorigenesis. Conclusion: Our comprehensive findings underscore the clinical significance of BRCA1/2 mutations in gastric cancer, advocating for further research to elucidate their mechanistic implications and therapeutic opportunities.
引用
收藏
页码:7898 / 7910
页数:13
相关论文
共 50 条
  • [11] Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies
    Rizzolo, Piera
    Silvestri, Valentina
    Ottini, Laura
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (01) : 199 - 200
  • [12] Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies
    Piera Rizzolo
    Valentina Silvestri
    Laura Ottini
    Breast Cancer Research and Treatment, 2017, 162 : 199 - 200
  • [13] Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory
    Strom, Charles M.
    Rivera, Steven
    Elzinga, Christopher
    Angeloni, Taraneh
    Rosenthal, Sun Hee
    Goos-Root, Dana
    Siaw, Martin
    Platt, Jamie
    Braastadt, Cory
    Cheng, Linda
    Ross, David
    Sun, Weimin
    PLOS ONE, 2015, 10 (08):
  • [14] Reliable assessment of BRCA1 and BRCA2 germline variants by next-generation sequencing: a multicenter study
    Zhang, Rui
    Gao, Peng
    Han, Yanxi
    Zhang, Runling
    Tan, Ping
    Zhou, Li
    Zhang, Jiawei
    Xie, Jiehong
    Li, Jinming
    BREAST CANCER, 2021, 28 (03) : 672 - 683
  • [15] Reliable assessment of BRCA1 and BRCA2 germline variants by next-generation sequencing: a multicenter study
    Rui Zhang
    Peng Gao
    Yanxi Han
    Runling Zhang
    Ping Tan
    Li Zhou
    Jiawei Zhang
    Jiehong Xie
    Jinming Li
    Breast Cancer, 2021, 28 : 672 - 683
  • [16] Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer
    Tacar, Seher Yildiz
    Bozgeyik, Esra
    Seber, Erdogan Selcuk
    Yetisyigit, Tarkan
    Tozkir, Hilmi
    Avci, Okan
    Arslan, Ahmet
    LIFE SCIENCES, 2020, 261
  • [17] Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study
    Omar Alejandro Zayas-Villanueva
    Luis Daniel Campos-Acevedo
    José de Jesús Lugo-Trampe
    David Hernández-Barajas
    Juan Francisco González-Guerrero
    María Fernanda Noriega-Iriondo
    Ilse Alejandra Ramírez-Sánchez
    Laura Elia Martínez-de-Villarreal
    BMC Cancer, 19
  • [18] Long-Range PCR and Next-Generation Sequencing of BRCA1 and BRCA2 in Breast Cancer
    Ozcelik, Hilmi
    Shi, Xuejiang
    Chang, Martin C.
    Tram, Eric
    Vlasschaert, Matt
    Di Nicola, Nando
    Kiselova, Anna
    Yee, Denise
    Goldman, Aaron
    Dowar, Mark
    Sukhu, Balram
    Kandel, Rita
    Siminovitch, Kathy
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (05): : 467 - 475
  • [19] Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history
    Salmi, Fatiha
    Maachi, Fatima
    Tazzite, Amal
    Aboutaib, Rachid
    Fekkak, Jamal
    Azeddoug, Houssine
    Jouhadi, Hassan
    PLOS ONE, 2021, 16 (07):
  • [20] Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer
    Choi, Min Chul
    Jang, Ja-Hyun
    Jung, Sang Geun
    Park, Hyun
    Joo, Won Duk
    Song, Seung Hun
    Lee, Chan
    Lee, Je Ho
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (02) : 308 - 315